Devin Antonovich, MD
Anesthesiology · West Columbia, SCNPI 1770036410
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.2%), grants and education — rather than concentrated in one kind of arrangement. Medtronic accounts for 73.3% of it on its own, with 29 other manufacturers making up the rest. Reporting peaked in 2020 at $5,397 and has fallen 86.4% since, to $734 in 2025. Among anesthesiology clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 185 payments — averaging $59.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$8K
- Nevro Corp.$452
- Vertos Medical, Inc.$390
- Tersera Therapeutics LLC$333
- Forte Bio-pharma LLC$289
- AbbVie$261
- plus $1K from 24 others
What the payments were for
- Grants$5,00045%
- Food & beverage$5,90153%
- Education$1832%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 69 | $8,126 |
| Nevro Corp. | 12 | $452 |
| Vertos Medical, Inc. | 9 | $390 |
| Tersera Therapeutics LLC | 13 | $333 |
| Forte Bio-pharma LLC | 15 | $289 |
| AbbVie | 13 | $261 |
| Abbott | 7 | $257 |
| Boston Scientific | 4 | $118 |
| Pfizer | 6 | $92 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $89 |
| SPR Therapeutics, Inc | 3 | $74 |
| GRT US Holding, Inc. | 3 | $65 |
| Globus Medical | 3 | $63 |
| Amneal Pharmaceuticals LLC | 3 | $48 |
| Smith+Nephew | 2 | $48 |
| Currax Pharmaceuticals LLC | 3 | $43 |
| Collegium Pharmaceutical, Inc. | 2 | $42 |
| Convatec Inc. | 1 | $34 |
| Bioventus LLC | 1 | $31 |
| Averitas Pharma Inc. | 1 | $30 |
| Biodelivery Sciences International, Inc. | 2 | $28 |
| Saluda Medical Americas, Inc. | 1 | $28 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $23 |
| IBSA Pharma Inc. | 1 | $22 |
| Johnson & Johnson | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
| Hikma Pharmaceuticals USA | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| Spinal Simplicity, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMED$5,000
- INTELLIS ADAPTIVESTIM$384
- INTELLIS$288
- VANTA ADAPTIVESTIM$274
- SYNCHROMEDII$234
- ASCENDA$142
- RESTORE$140
- mild Device Kit$114
- OCTRODE$110
How this compares
$11,084 in reported general payments places this provider in the 95th percentile of 609 anesthesiology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 40 | $30,147 |
| LinzessLinaclotide | 29 | $24,040 |
| MovantikNaloxegol Oxalate | 50 | $21,952 |
| OxycontinOxycodone Hcl | 37 | $19,909 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 587 | $17,903 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 414 | $10,852 |
| Lidocaine | 56 | $8,523 |
| Diclofenac Sodium | 73 | $5,220 |
| Morphine Sulfate ErMorphine Sulfate | 134 | $4,713 |
| Fentanyl | 42 | $3,515 |
| Gabapentin | 226 | $3,374 |
| Tramadol Hcl ErTramadol Hcl | 38 | $2,861 |
| Oxycodone Hcl | 180 | $2,685 |
| Naloxone Hcl | 34 | $2,425 |
| Celecoxib | 31 | $2,245 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $42 | $30,14740 claims |
| AbbVieLinzess | $261 | $24,04029 claims |
| Hikma Pharmaceuticals USAMorphine Sulfate | $16 | $1,69046 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 609 anesthesiology providers in South Carolina.
Other anesthesiology in West Columbia
- David KingeryWest Columbia$3K
- Frank OverdykCharleston$131K
- Frank HumblesConway$74K
- Joseph RodrigoCharleston$54K
- Jeffrey FrohockCharleston$48K
- Eric LoudermilkAnderson$21K
- David ArcellaCharleston$18K
- William HandGreenville$16K
- David HallGreenville$16K
- Blake LecheAnderson$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.